These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9257085)

  • 21. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter.
    Kowey PR; VanderLugt JT; Luderer JR
    Am J Cardiol; 1996 Oct; 78(8A):46-52. PubMed ID: 8903276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
    Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population.
    Delle Karth G; Schillinger M; Geppert A; Haumer M; Gwechenberger M; Meyer B; Heinz G; Siostrzonek P
    Wien Klin Wochenschr; 2005 Feb; 117(3):92-7. PubMed ID: 15773423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.
    Gowda RM; Punukollu G; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Am J Ther; 2003; 10(4):259-63. PubMed ID: 12845389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators.
    Abi-Mansour P; Carberry PA; McCowan RJ; Henthorn RW; Dunn GH; Perry KT
    Am Heart J; 1998 Oct; 136(4 Pt 1):632-42. PubMed ID: 9778066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter.
    Malviya A; Kapoor M; Sivam RKN; Khan SA; Pandey R; Kumar U; Ete T; Mishra A
    Indian Heart J; 2020; 72(4):283-288. PubMed ID: 32861384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.
    Eversole A; Hancock W; Johns T; Lopez LM; Conti CR
    Clin Cardiol; 2001 Jul; 24(7):521-5. PubMed ID: 11444644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter.
    Rogers KC; Wolfe DA
    J Emerg Med; 2001 Jan; 20(1):67-71. PubMed ID: 11165840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.
    VanderLugt JT; Mattioni T; Denker S; Torchiana D; Ahern T; Wakefield LK; Perry KT; Kowey PR
    Circulation; 1999 Jul; 100(4):369-75. PubMed ID: 10421596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
    J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide.
    Obel OA; Camm AJ
    Drugs Aging; 1998 Jun; 12(6):461-76. PubMed ID: 9638394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ibutilide in rapid conversion of atrial flutter in octogenarians.
    Antonicelli R; Testarmata P; Recanatini A
    Drugs Aging; 2002; 19(10):787-91. PubMed ID: 12390055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and electrophysiologic effects of calcium channel blockers in patients receiving ibutilide.
    Wood MA; Gilligan DM; Brown-Mahoney C; Nematzadeh F; Stambler BS; Ellenbogen KA
    Am Heart J; 2002 Jan; 143(1):176-80. PubMed ID: 11773930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department.
    Vinson DR; Lugovskaya N; Warton EM; Rome AM; Stevenson MD; Reed ME; Nagam MR; Ballard DW;
    Ann Emerg Med; 2018 Jan; 71(1):96-108.e2. PubMed ID: 28969929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
    Oral H; Souza JJ; Michaud GF; Knight BP; Goyal R; Strickberger SA; Morady F
    N Engl J Med; 1999 Jun; 340(24):1849-54. PubMed ID: 10369847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
    Patsilinakos S; Christou A; Kafkas N; Nikolaou N; Antonatos D; Katsanos S; Spanodimos S; Babalis D
    Am J Cardiol; 2010 Sep; 106(5):673-6. PubMed ID: 20723644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
    Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R
    Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion.
    Domanovits H; Schillinger M; Thoennissen J; Nikfardjam M; Janata K; Brunner M; Laggner AN
    Resuscitation; 2000 Aug; 45(3):181-7. PubMed ID: 10959017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.